CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Lucy Scientific Discovery Inc   (LSDI)
Other Ticker:  
 

Lucy Scientific Discovery Inc 's Total Debt to Equity

LSDI's quarterly Total Debt to Equity and Total Debt, Equity growth


In Spite of the debt repayement of -95.67%, in II Quarter 2023 ,Total Debt to Equity deteriorated to 0.75 reached a new all-time high.

Within Major Pharmaceutical Preparations industry in the second quarter 2023, 13 other companies have achieved lower Total Debt to Equity than Lucy Scientific Discovery Inc in the II Quarter 2023. While Total Debt to Equity total ranking has improved so far in the second quarter 2023 to 503, from total ranking in the first quarter 2023 at 1173 .

Explain Debt to Equity Ratio?
What is the structure of LSDI´s Total Debt?
How valuable is the LSDI´s Equity?


LSDI Total Debt to Equity (Dec 31 2023)
II. Quarter		 (Sep 30 2023)
I. Quarter		 (Jun 30 2023)
IV. Quarter		 (Mar 31 2023)
III. Quarter		 (Dec 31 2022)
II. Quarter
Y / Y Equity Change - - - - -
Y / Y Total Debt Change -98.58 % - - - -
Total Debt to Equity MRQ 0.75 0.52 0.01 0.01 -
LSDI's Total Ranking # 503 # 1173 # 132 # 109 # 0
Seq. Equity Change -97 % -42.25 % -21.46 % - -
Seq. Total Debt Change -95.67 % 2213.01 % 2.21 % -98.62 % -

New: More LSDI's historic Total Debt to Equity Ratios >>


Total Debt to Equity second quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 14
Healthcare Sector # 53
Overall Market # 503


Total Debt to Equity Statistics
High Average Low
0.75 0.32 0.01
(Dec 31 2023)   (Mar 31 2023)




Financial Statements
Lucy Scientific Discovery Inc 's Equity $ 0 Millions Visit LSDI's Balance sheet
Lucy Scientific Discovery Inc 's Total Debt $ 0 Millions Visit LSDI's Balance sheet
Source of LSDI's Sales Visit LSDI's Sales by Geography


Cumulative Lucy Scientific Discovery Inc 's Total Debt to Equity

LSDI's Total Debt to Equity for the trailling 12 Months

LSDI Total Debt to Equity

 (Dec 31 2023)
II. Quarter		 (Sep 30 2023)
I. Quarter		 (Jun 30 2023)
IV. Quarter		 (Mar 31 2023)
III. Quarter		 (Dec 31 2022)
II. Quarter
Y / Y Equity TTM Growth - - - - -
Y / Y Total Debt TTM Growth -98.58 % - - - -
Total Debt to Equity TTM 0.12 0.88 1.14 - -
Total Ranking TTM # 1513 # 1277 # 160 # 127 # 0
Seq. Equity TTM Growth -97 % -42.25 % -21.46 % - -
Seq. Total Debt TTM Growth -95.67 % 2213.01 % 2.21 % -98.62 % -

Debt to equity ratio ranking by company, industry and sector >> Back to LSDI Financial Strength Comparisons >> Go to Compare LSDI Total Debt to Equity Ratio to its Competitors

On the trailing twelve months basis Due to debt repayement of -95.67% Lucy Scientific Discovery Inc decreased Total Debt to Equity in the 12 months ending in II Quarter 2023 to 0.12, a new company low.
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 79, during the past 12 months, other companies have achieved lower Total Debt to Equity than Lucy Scientific Discovery Inc . While Total Debt to Equity total ranking has deteriorated during the twelve months ending in the II Quarter 2023, compared to the prior period, from 1277 to 1513.

Explain Debt to Equity Ratio?
What is the structure of LSDI´s Total Debt?
How valuable is the LSDI´s Equity?

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 80
Healthcare Sector # 205
Within the Market # 1513


trailing twelve months Total Debt to Equity Statistics
High Average Low
0.88 0.5 0.12
(Sep 30 2023)   (Dec 31 2023)




Companies with similar Total Debt to Equity in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Total Debt to EquityDec 31 2023 MRQ Total DebtDec 31 2023 MRQ Equity
Travere Therapeutics Inc   1.88 $ 377.263  Millions$ 200.810  Millions
Phibro Animal Health Corporation  1.75 $ 474.898  Millions$ 270.803  Millions
Ionis Pharmaceuticals Inc  1.68 $ 648.453  Millions$ 386.686  Millions
Eyenovia inc   1.59 $ 14.287  Millions$ 8.999  Millions
Jazz Pharmaceuticals Plc  1.53 $ 5,712.942  Millions$ 3,736.997  Millions
Mallinckrodt Plc  1.52 $ 1,762.400  Millions$ 1,160.200  Millions
G1 Therapeutics Inc   1.46 $ 51.557  Millions$ 35.386  Millions
Xoma Corporation  1.40 $ 124.061  Millions$ 88.721  Millions
Alimera Sciences Inc   1.40 $ 64.489  Millions$ 46.170  Millions
Biovie Inc   1.36 $ 10.195  Millions$ 7.491  Millions
Catalent Inc   1.36 $ 5,005.000  Millions$ 3,687.000  Millions
Bristol myers Squibb Company  1.35 $ 39,772.000  Millions$ 29,485.000  Millions
Emergent Biosolutions Inc   1.32 $ 860.200  Millions$ 649.300  Millions
Zoetis Inc   1.32 $ 6,567.000  Millions$ 4,991.000  Millions
Soligenix inc   1.29 $ 3.261  Millions$ 2.522  Millions
Summit Therapeutics Inc   1.29 $ 100.000  Millions$ 77.692  Millions
Clene Inc   1.23 $ 16.521  Millions$ 13.390  Millions
Lexicon Pharmaceuticals Inc   1.07 $ 99.508  Millions$ 93.110  Millions
Merck and Co Inc   0.93 $ 35,055.000  Millions$ 37,635.000  Millions
Elanco Animal Health Inc  0.93 $ 5,774.000  Millions$ 6,223.000  Millions
Pds Biotechnology Corp  0.91 $ 23.673  Millions$ 26.131  Millions
Viatris Inc   0.89 $ 18,131.500  Millions$ 20,467.400  Millions
Perrigo Company Plc  0.85 $ 4,073.400  Millions$ 4,767.900  Millions
Ocular Therapeutix Inc   0.82 $ 74.925  Millions$ 91.131  Millions
Agex Therapeutics Inc   0.81 $ 4.365  Millions$ 5.358  Millions
Biofrontera Inc   0.81 $ 3.904  Millions$ 4.793  Millions
Pfizer Inc  0.81 $ 71,888.000  Millions$ 89,288.000  Millions
Casi Pharmaceuticals inc   0.78 $ 18.895  Millions$ 24.165  Millions
Cryoport inc   0.78 $ 380.037  Millions$ 489.023  Millions
Prestige Consumer Healthcare Inc   0.75 $ 1,199.340  Millions$ 1,600.577  Millions

Date modified: 2024-02-14T09:21:55+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com